Meet our lab operations experts
MDisrupt Lab Operations Experts
We are the experts in finding you health industry experts. The key to success in building healthtech products that scale is engaging health industry experts early and often. Explore all available experts below. We can help.
Laboratory Business Consultant
Dynamic leader skilled planning, developing, and implementing organizational and operational capability within early stage biotech companies. Demonstrated ability across diverse scientific, business, and investor stakeholders. Expertise establishing clinical laboratories, across genomic, pharmacogenomic, and “multi-omic” domains.
Key Skills:
- Laboratory Operations
- Product Management
- Regulatory Compliance
- Genetic Testing
Chief Medical Officer
30+ yrs experience in molecular diagnostics in regional and academic medical centers, biotech startups, and the reference lab settings. Expertise extends beyond molecular diagnostics to regulatory affairs and strategic considerations.
Key Skills:
- Molecular Diagnostics
- Regulatory Affairs
- Health Policy Trends Insights
- Executive Leadership
Clinical Laboratory Consultant
Versatile leader with 15+ years of laboratory experience in creating, implementing and improving quality management systems. Guide labs through accreditation, licensure, organize and prepare staff, records and documentation for audits by accreditation and state agencies. Experienced assay validation and data review.
Key Skills:
- Compliance, Quality Assurance (CLIA/CAP/NYS)
- Draft Policies and Procedures
- Auditor
- Clinical Chemistry and Molecular Genetics
Chief Medical Officer
An experienced molecular pathologist with extensive executive experience in the genomics and biotech industry. Expertise ranges from test development, laboratory operations, medical affairs and medical/reimbursement strategy including being an accomplished communicator.
Key Skills:
- Medical/Scientific Strategy
- Evidence Development
- Reimbursement Strategy
- Genomic Medicine
Physician Innovator
Clinical Pathologist with subspecialty training in Molecular Genetics Pathology and Pathology Informatics, board-certified in Clinical Pathology, Molecular Genetics Pathology and Clinical Informatics with significant experience in digital imaging and telepathology, genomics and medical research. A particular focus on workflow analysis and process change, automation, improved human-computer interaction, and data analytics.
Key Skills:
- Molecular Genetics Pathology
- Clinical Informatics
- Clinical Pathology
- Health Information Systems and Analytics
Find Your Expert
Whether your company is early-stage or well-established, we connect you to the expertise you need to accelerate your health product’s path to market.
Medical
Commercial
Legal and Health Policy
Scientific
Market Access and Reimbursment
Regulatory and Compliance
Lab Operations
Join Us! Become an MDisruptor.
At MDisrupt, we match practicing health professionals to healthtech companies seeking to build clinically and commercially viable products. We handle the details, allowing you to do what you do best.
Experts Needed
- Physicians
- Scientists
- Regulatory Experts
- Health Economists
- Lab Test Designers
- Market Access Experts
- Commercial Strategist
- Clinical Trial Designers
Opportunities
- Expert in Residence
- Strategic Advisor
- Key Opinion Leadership
- Advisory Boards
- Focus Groups
- Consulting Projects
Check out our blog
Using Digital Health Tools to Strengthen the Doctor-Patient Relationship
Digital health has so much potential—we can’t alienate doctors from it, because it’s the future. If physicians and digital health teams work together, we can make these products all the more robust and meaningful for patients.
How Precision Medicine Can Transform Healthcare
“We know that the way we are spending money in healthcare is not working. So everything will change into value-based care and precision medicine will play a critical role there.”
Overly White Genetic Databases = Decades More Health Disparities
“Without significant changes, the genetic data we use to create the next generation of diagnostics, disease risk assessments, and therapeutic interventions will continue to make precision medicine available only to those of European descent.”